Author:
Prathyusha A. M. V. N.,Naidu B. Prathap,Veera Bramhachari Pallaval
Reference54 articles.
1. Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, Tutino M et al (2013) Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg 100(1):144–150
2. Amal H, Leja M, Funka K, Lasina I, Skapars R, Sivins A et al (2016) Breath testing as potential colorectal cancer screening tool. Int J Cancer 138(1):229–236
3. Armitage EG, Southam AD (2016) Monitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomics. Metabolomics 12(9):146
4. Broza YY, Vishinkin R, Barash O, Nakhleh MK, Haick H (2018) Synergy between nanomaterials and volatile organic compounds for non-invasive medical evaluation. Chem Soc Rev 47(13):4781–4859
5. Buck A, Aichler M, Huber K, Walch A (2017) In situ metabolomics in cancer by mass spectrometry imaging. In: Advances in cancer research, vol 134. Academic, Cambridge, pp 117–132